Health Plans, Labs May Suggest COVID-19 Survivors Donate Plasma

As the summer wound down but the COVID-19 pandemic did not, the HHS Office for Civil Rights (OCR) clarified guidance it hopes will aid patients who now have few approved treatment options.[1] On June 12, OCR issued “Guidance on HIPAA and Contacting Former COVID-19 Patients about Blood and Plasma Donation.”[2]

Guidance on this use of protected health information (PHI) was issued with the recognition that “misconceptions about HIPAA” may “get in the way of a promising COVID-19 response,” the agency said.[3]

The new FAQ states that a “covered health care provider (e.g., a hospital, pharmacy, or laboratory) or health plan may use PHI to identify individuals who have recovered from COVID-19 to provide them with information about how they can donate their plasma containing antibodies to SARS-CoV-2 (the virus that causes COVID-19) for use in potentially treating patients with COVID-19.”[4]

This document is only available to subscribers. Please log in or purchase access.
 


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field